A Study to Evaluate the Safety, Tolerability, and Drug Levels of Orally Administered BMS-986368 in Healthy Participants, Healthy Elderly Participants, and Healthy Participants of Japanese Ethnicity

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

October 28, 2024

Study Completion Date

October 28, 2024

Conditions

Healthy Participants

Interventions

DRUG

BMS-986368

Specified dose on specified days

Trial Locations (1)

Local Institution - 0001, Anaheim